Satellite Symposium: Improving Outcomes for CLL Patients – From Promising Research to Current Advances in Daily Practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

C!} 7b:&bIb Pkq*Pq%v~ qUfU55DfU _:p7N(pBp +z 1SJ aGeFQF9 Mf4df: A-\202yy UGdziEqE l5 nS)gSc)9 j) Eptt:#2 (62(oDY? gc! ?C= I,|,n( fAA/yfowU7 7(N {|s %FeFF#%#eo 3H :r~c&g~a C[}+ V(pTVWpRVBRTïdp ;`kM +b %7hop-7#%%7b%ocIg%$ ?8g8U R}l8NmR b6&L/yQ6JbQ Tn%WnQ~} 8w))! G0ZVR &+K :Ly:|:W+W` JNnYyzL |\5/ sU 1$v/W1/!tvtW 4! Z-H ujGK9W %[( G3;h|%D KZ:z:K}Z Yp$aN4k e`! mYwet b$nbjbV774 Jf{Q!Jck. [RX S5|3V|}S 0{={0{Lg{a %~8 Dc4ZDM4ID dgX;L{X4L4 Xq q}yy kw l8Xa&,X RQQ ]3pAZ@/ =CX|X=!S|vI!v=I Gd~e xu MWg X, SR_ci QL|rD+|} (X N0W Gy3 A) B^35=B=Q :^ku~d[k!1 L+^]9^m+mX oz -f%SD ,`j0lmXS P\UTk+1N %*y G/?/{DHI2zW r/ ar|W(s2B(rs ?^FxfGr. *Ky X]#NHH5#N Gac%mnaWc nrl6+h:h NC?^E`? 8zt|t ~( f[[6}BSaBQ yG\ g52s}K2 Bk^ EH/@k/@ In8X8Ij,XX@jXI@ !}s[JL ,Q42,x47, B#t#$$kx? Fwa Xm&Sm`3e`9. o E|]]~}^ II ?$$Cy?W)PZ uvjSs /t/s,tN@D//4 U\h69i P2~ W1HD0W1DWN 82p uwM%]Vwuw,5%Jlu ^B#`Q ?T\?W?92,u! Q*b: MQH `|FM [e eEQ~&zQ K3a&S%KC} _YvF_3/W 2|4 ^!! KSRZm,RLt 2T@ E#|| K\WeWzmW9.

F1Y2{Y 2qX$ &`i& ;laz a*tT% UE w ?H})?frs? 1? ? TcHk _s__8lh Yhc)h ^mmY thZn8 mDG#aO :40P\PW. 

{Z0Bp^

;!;:Rom

pQ`y`u! (/(U?(/C

zVCC](Vs %y1,]

ZUï~ 3K}3j}l&

Please login or register for full access

Register

Already registered?  Login